| name | pdm-contraception-use |
| description | Recommends contraception when pregnancy is not desired for individuals with diabetes who could become pregnant. Triggered by discussions about pregnancy planning, contraception needs, or when pregnancy is not desired. |
Recommend contraception when pregnancy is not desired in individuals with diabetes
STEP 1 — Gather Information
Assess pregnancy intention, current contraceptive use, medical history (type of diabetes, comorbidities, medications, BMI, blood pressure), and reproductive goals. Document whether pregnancy is desired or not desired.
STEP 2 — Rule In / Rule Out
If pregnancy is desired → proceed to preconception care counseling; if pregnancy is not desired → proceed to contraception counseling.
STEP 3 — Classify or Stratify
Stratify contraceptive options using US Medical Eligibility Criteria (MEC) for women with diabetes:
| Condition | Typical MEC Category | Examples |
|---|
| No vascular complications | 1 (no restriction) or 2 (advantages > risks) | IUD, implant, progestin-only pill |
| Hypertension, nephropathy, or other vascular disease | 3 (risks > benefits) or 4 (unacceptable risk) for combined hormonal methods | Avoid estrogen-containing pills/patch/ring; prefer IUD, implant, progestin-only |
| Obesity (BMI ≥30) | 2 for most methods; monitor for VTE risk with estrogen-containing | Consider IUD, implant, progestin-only |
| Select method based on MEC category, efficacy, and patient preference. | | |
STEP 4 — Decide
Initiate shared decision‑making to choose a contraceptive method aligned with MEC stratification and patient values; provide noncoercive counseling and prescribe or refer for the selected method.
Clinical Guardrails / Mimics / Pitfalls
- Ensure counseling is patient‑centered and free of coercion; respect autonomy.
- Avoid prescribing estrogen‑containing contraceptives in women with established vascular disease, nephropathy, or retinopathy (US MEC 3/4).
- Do not assume pregnancy desire; always ask explicitly.
- Do not overlook drug‑drug interactions (e.g., enzyme‑inducing antiepileptics reducing hormonal efficacy).
- Do not delay contraception provision while awaiting preconception optimization if pregnancy is truly not desired.
Concrete Clinical Example
A 30‑year‑old woman with type 2 diabetes, BMI 31, hypertension controlled on lisinopril, states she does not desire pregnancy for the next 2 years. After reviewing US MEC, a levonorgestrel IUD (category 2) is chosen. She receives counseling on insertion, benefits, and risks, and the IUD is placed during the visit.
Source: Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline, Endocrine Society/European Society of Endocrinology, 2025, https://doi.org/10.1210/clinem/dgaf288
